Efficacy of Voriconazole in the Treatment of Invasive Fungal Infection in Pediatric Intensive Care Unit

Han Long; Liu Chang; Yan Meixing

doi:10.13407/j.cnki.jpp.1672-108X.2021.10.012

您当前的位置：

首页 >

文章列表页 >

Efficacy of Voriconazole in the Treatment of Invasive Fungal Infection in Pediatric Intensive Care Unit

更新时间：2022-11-03

- Efficacy of Voriconazole in the Treatment of Invasive Fungal Infection in Pediatric Intensive Care Unit
- Vol. 27, Issue 10, Pages: 40-43(2021)
- 作者机构：
  
  青岛市妇女儿童医院,山东,青岛,266000
- 作者简介：
- 基金信息：
- DOI：10.13407/j.cnki.jpp.1672-108X.2021.10.012
  CLC：
- Published：2021，
  
  Published Online：10 October 2021，
扫描看全文
Han Long, Liu Chang, Yan Meixing. Efficacy of Voriconazole in the Treatment of Invasive Fungal Infection in Pediatric Intensive Care Unit. [J]. 27(10):40-43(2021)
DOI：

Han Long, Liu Chang, Yan Meixing. Efficacy of Voriconazole in the Treatment of Invasive Fungal Infection in Pediatric Intensive Care Unit. [J]. 27(10):40-43(2021) DOI： 10.13407/j.cnki.jpp.1672-108X.2021.10.012.

摘要

目的：探讨伏立康唑在儿童重症监护室（PICU）治疗侵袭性真菌感染的临床疗效。方法：收集2019年9月至2020年5月住院期间使用伏立康唑进行真菌感染治疗的PICU患儿25例，分析患儿的用药目的、宿主因素、影像学表现、微生物检查以及治疗效果。结果：伏立康唑在PICU治疗侵袭性真菌感染的总有效率为52.0%，临床诊断治疗比拟诊治疗的用药疗程长且差异有统计学意义。患儿合并细菌感染、性别、诊断级别（拟诊和临床诊断）和年龄（<2岁和≥2岁）对伏立康唑的有效性比较差异均无统计学意义。伏立康唑治疗曲霉菌有效率为85.7%，治疗念珠菌有效率为28.6%，差异有统计学意义。结论：伏立康唑治疗侵袭性真菌感染有效率较低的原因可能与PICU的患儿基础疾病复杂，导致抗真菌治疗无法得到有效控制有关。伏立康唑对侵袭性曲霉菌病效果显著，对念珠菌治疗效果较差。是否合并细菌感染、性别、诊断级别和年龄不影响伏立康唑的有效性。

Abstract

Objective: To probe into the clinical efficacy of voriconazole in the treatment of invasive fungal infection in children in pediatric intensive care unit (PICU). Methods: Twenty-five children from PICU who were treated with voriconazole for fungal infection during hospitalization from Sept. 2019 to May 2020 were extracted to analyze the purpose of medication

host factors

imaging manifestations

microbial examination and therapeutic effects. Results: The total effective rate of voriconazole in the treatment of invasive fungal infection in PICU was 52.0%. Clinical diagnosis had longer treatment course than proposed diagnosis and the difference was statistically significant. There were no statistically significant difference in the efficacy of voriconazole for children with co-infection

gender

diagnostic level (proposed and clinical diagnosis) and age (<2 and ≥2 years old). The effective rate of voriconazole was 85.7% for Aspergillus and 28.6% for Candida

the difference was statistically significant. Conclusion: The reason for the low effective rate of voriconazole in the treatment of invasive fungal infection may be related to the complicated underlying diseases of children from PICU

leading to the ineffective control of antifungal therapy. Voriconazole has significant effect on invasive Aspergillosis

but poor effect on Candida. The presence or absence of co-infection

gender

diagnostic level and age do not affect the efficacy of voriconazole.

关键词

伏立康唑儿童重症监护室侵袭性真菌感染有效性

Keywords

oriconazolepediatric intensive care unitnvasive fungal infectionefficacy

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Systematic Review on Efficacy and Safety of Zoledronic Acid in the Treatment of Bone Metabolic Disordersin Children

Analysis of Pharmaceutical Care on the Use of Voriconazole in Pediatric Liver Transplantation Patients Younger Than 2 Years of Age

Efficacy and Safety of Tanreqing Injection in the Treatment of Children with Viral Pneumonia: a Meta-Analysis

Clinical Characteristics Analysis of 89 Children with Invasive Pulmonary Fungal Infection

Clinical Application of Therapeutic Drug Monitoring of Voriconazole in Children with Hematological Disease

Related Author

Li Huiying

Li Yunwei

Liu Yan

Shen Jianling

Lyu Mengwei

Tu Caixia

Yang Yanming

Ren Danyang

Related Institution

Kunming Children’s Hospital / Children’s Hospital of Kunming Medical University, Kunming

Kunming MedicalUniversity, Kunming

Beijing Friendship Hospital, Capital Medical University

The Central Hospital of Enshi Tujia andMiao Autonomous Prefecture, Hubei Enshi

Children’ s Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of ChildDevelopment and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and TechnologyCooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing

⁰